Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ultima Genomics

Explore full profile

DNA sequencing with its UG 100™ platform, delivering ultra‑high throughput and cost‑effective omics solutions that aim to make the $100 genome a reality

Fremont, United StatesFounded 2016Health Tech & Medtech
Valuation $1–2.5B Last recorded · 2022
Revenue $100–500M Latest reported FY
Headcount 100–500 Current team size
Total funding $500M–1B Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Ultima Genomics and the history behind them.

About Ultima Genomics

Ultima Genomics is a pioneering company in the genomics industry, dedicated to advancing human health through innovative genomic sequencing technologies. The company operates in the high-throughput genomics market, which involves processing large volumes of genetic data to uncover insights into human biology and disease. Ultima Genomics serves a diverse range of clients, including academic researchers, pharmaceutical companies, and healthcare providers, who require comprehensive and precise genomic data for their work.

The core of Ultima Genomics' business model is its revolutionary sequencing architecture, which significantly enhances the breadth, depth, and frequency of genomic data collection. "Breadth" refers to the ability to gather extensive data from each sample, "depth" means detecting even the smallest genetic variations, and "frequency" involves conducting routine tests for early disease detection and monitoring. By excelling in these areas, Ultima Genomics provides its clients with unparalleled access to high-quality genomic information.

Ultima Genomics generates revenue by offering its advanced sequencing services and technologies to clients who need detailed genomic data for research and clinical applications. The company also partners with other organizations to drive forward the scale of genomic information, enabling groundbreaking discoveries and improvements in human health. By continuously innovating and expanding its capabilities, Ultima Genomics aims to help its customers achieve what was previously considered impossible in the field of genomics.

In summary, Ultima Genomics is at the forefront of the genomics revolution, providing cutting-edge sequencing solutions that empower researchers and healthcare professionals to make significant strides in understanding and treating diseases.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
Fremont, United States
Sector
Health Tech & Medtech
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

Series B and later8 investors entered at this stage

Employees mapped 309 incl. 11 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 13 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇺🇸 United States79.5%
🇮🇱 Israel15.8%
🇬🇧 United Kingdom1.9%
🇰🇷 South Korea0.8%
🇨🇦 Canada0.4%
Top 5 of 7 shown
Web traffic by country
9.7K monthly visits
across markets
🇺🇸 United States69.1%
🇮🇳 India14.4%
🇬🇧 United Kingdom7.2%
🇮🇱 Israel6.2%
🇮🇩 Indonesia2.1%
Top 5 markets shown

Patents

Estimated portfolio value
$33M

67 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ultima Genomics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ultima Genomics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.